Korva rescues the ideas worth keeping from podcasts. Each one becomes a Card.
From This Week in StartupsWhy this longevity startup raised in Japan, not Silicon Valley | TWiST Tokyo | E2315
Cell-therapy quality control asks three questions: Is the batch potent, authentic, and consistent with the next batch?
Don't lose this one.
Save this Card and explore the idea further in Korva.